Joined Today: 17

RGN Regenerx Biopharmaceuticals, Stock Message Board

All Messages

RGN Message Board Home | Join The RGN Group |

#34: Wall Street Reporter Features Exclusive Video Interviews with CEO's of BioMS Medical Corp., RegeneRx Biopharmaceuticals, Inc., and Canopus BioPharma
FastFun	December 13, 2007 07:11:50 AM
NEW YORK, Nov. 23, 2007 (PRIME NEWSWIRE) -- Wall Street Reporter conducted exclusive interviews with the CEO's of BioMS Medical Corp. (TSX:MS); RegeneRx Biopharmaceuticals, Inc.... view message ignore post recommend post

#33: German and U.S. Researchers Show TB4's Cardioprotective Effects in Ischemia-Reperfusion Injury
FastFun	December 13, 2007 07:11:24 AM
Porcine Data Presented at American Heart Association Meeting REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced that this afternoon at an American Heart... view message ignore post recommend post

#32: RegeneRx Receives First Ophthalmic Wound-Healing Patent in China
FastFun	December 13, 2007 07:10:50 AM
REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it has received official notice from Chinese Patent Office (CSIPO) that CSIPO intends to grant a... view message ignore post recommend post

#31: Interview with J.J. Finkelstein
StockPro	April 5, 2007 02:59:33 PM
CEO of RegeneRx Biopharmaceuticals, Inc. J.J. Finkelstein's interview is now online at Wall Street Reporter website view message ignore post recommend post

#30: RGN News RegeneRx Biopharmaceuticals, Inc. Reports 2006 Year-End Results
NewsBot	April 2, 2007 05:30:00 AM
BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX: RGN), announced today the results for its year ended December 31, 2006. The company reported a net loss of $8.3... view message ignore post recommend post

#29: RGN News RegeneRx Files IND to Begin Phase 2 Ophthalmic Clinical Trial
NewsBot	March 30, 2007 07:00:00 AM
BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced that it has filed an Investigational New Drug Applications (IND) with the U.S.... view message ignore post recommend post

#28: RGN News RegeneRx Files First IND for Cardiovascular Clinical Program
NewsBot	March 30, 2007 06:04:00 AM
BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced that it has filed an Investigational New Drug Applications (IND) with the U.S.... view message ignore post recommend post

#27: RGN News RegeneRx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year End 2006 Earnings Release and Conference Call
NewsBot	March 27, 2007 11:53:00 AM
BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN), today announced that it will report fourth quarter and year end 2006 results before the market opens on... view message ignore post recommend post

#26: RGN News RegeneRx Reports Preliminary Cardiovascular Data at Thymosin Meeting
NewsBot	March 26, 2007 05:30:00 AM
BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) reported on Saturday, March 24th at the First Annual Symposium on Thymosins in Health and... view message ignore post recommend post

#25: RGN News RegeneRx to Present at First Annual Symposium on Thymosins in Health and Disease
NewsBot	March 19, 2007 06:08:00 AM
BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) reported today that it will be participating in the First Annual Symposium on Thymosins... view message ignore post recommend post

#24: RGN News Researchers Find that TB4 Increases Gene Expression of Key Wound Healing Enzyme in the Cornea
NewsBot	March 12, 2007 05:03:00 AM
BETHESDA, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (Amex:RGN) (www.regenerx.com) reported today that researchers at the Wayne State University School of Medicine and the... view message ignore post recommend post

#23: RGN News RegeneRx Receives First Patent for Treating Wounds and Other Disorders of the Eye
NewsBot	March 6, 2007 08:57:00 AM
BETHESDA, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (Amex:RGN) (www.regenerx.com) announced today that it received its first patent related to the ability of its lead drug... view message ignore post recommend post

#22: RGN News Dr. Deepak Srivastava Joins RegeneRx Medical and Scientific Advisory Board
NewsBot	March 5, 2007 05:30:00 AM
BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (Amex:RGN) (www.regenerx.com) reported today that Dr. Deepak Srivastava has joined RegeneRx’s Medical and... view message ignore post recommend post

#21: RGN News Researchers Find RegeneRx's TB4 Inhibits Activation of Key Inflammatory Molecule - NFkB
NewsBot	January 23, 2007 09:45:00 AM
BETHESDA, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (Amex:RGN) (www.regenerx.com) reported today that researchers at the Wayne State University School of Medicine and... view message ignore post recommend post

#20: RGN News RegeneRx to Present at the American Stock Exchange's First Annual Healthcare Investor Conference
NewsBot	January 23, 2007 06:00:00 AM
BETHESDA, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (Amex:RGN) (www.regenerx.com) announced today its participation in the American Stock Exchange’s First Annual... view message ignore post recommend post

Group Home | Login if you want to post a message